» Articles » PMID: 7699325

Dual T Cell Receptor Beta Chain Expression on Human T Lymphocytes

Overview
Journal J Exp Med
Date 1995 Apr 1
PMID 7699325
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Allelic exclusion of lymphocyte antigen receptor chains has been hypothesized as a mechanism developed by the immune system to ensure efficient lymphocyte repertoire selection and tight control of lymphocyte specificity. It was effectively shown to be operative for both the immunoglobulin (Ig) and the T cell receptor (TCR) beta chain genes. Our present observations suggest that close to 1% of human T lymphocytes escape this allelic control, and express two surface TCR beta chains with distinct superantigenic reactivities. Since this high frequency of dual beta chain expressors did not result in any dramatic immune dysregulations, these results question the need for a mechanism ensuring clonal monospecificity through allelic exclusion.

Citing Articles

Demonstration of T-Cell Monotypia Using Anti-TCRbeta1/2 (/2) Immunostaining as a Rapid and Cost-Effective Alternative to PCR-Based Clonality Studies for the Diagnosis of T-Cell Lymphoma.

Soilleux E, Rodgers D, Situ J, Evans S, Konda V, Yang H Diagnostics (Basel). 2024; 14(22).

PMID: 39594145 PMC: 11593183. DOI: 10.3390/diagnostics14222479.


Mathematical Characterization of Private and Public Immune Receptor Sequences.

Bottcher L, Wald S, Chou T Bull Math Biol. 2023; 85(10):102.

PMID: 37707621 PMC: 10501991. DOI: 10.1007/s11538-023-01190-z.


Molecular mimicry and autoimmunity in the time of COVID-19.

Rojas M, Herran M, Ramirez-Santana C, Leung P, Anaya J, Ridgway W J Autoimmun. 2023; 139:103070.

PMID: 37390745 PMC: 10258587. DOI: 10.1016/j.jaut.2023.103070.


Dual TCR-Expressing T Cells in Cancer: How Single-Cell Technologies Enable New Investigation.

Muhowski E, Rogers L Immunohorizons. 2023; 7(5):299-306.

PMID: 37129560 PMC: 10354877. DOI: 10.4049/immunohorizons.2200062.


Biomolecular Mechanisms of Autoimmune Diseases and Their Relationship with the Resident Microbiota: Friend or Foe?.

Topi S, Bottalico L, Charitos I, Colella M, Di Domenico M, Palmirotta R Pathophysiology. 2022; 29(3):507-536.

PMID: 36136068 PMC: 9505211. DOI: 10.3390/pathophysiology29030041.


References
1.
Moreau J, Bonneville M, Peyrat M, Godard A, Jacques Y, Desgranges C . T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest. 1986; 78(4):874-9. PMC: 423705. DOI: 10.1172/JCI112674. View

2.
Carrel S, Isler P, Schreyer M, Vacca A, Salvi S, GIUFFRE L . Expression on human thymocytes of the idiotypic structures (Ti) from two leukemia T cell lines Jurkat and HPB-ALL. Eur J Immunol. 1986; 16(6):649-52. DOI: 10.1002/eji.1830160610. View

3.
Wilson A, DAmico A, Ewing T, Scollay R, Shortman K . Subpopulations of early thymocytes. A cross-correlation flow cytometric analysis of adult mouse Ly-2-L3T4-(CD8-CD4-) thymocytes using eight different surface markers. J Immunol. 1988; 140(5):1461-9. View

4.
Uematsu Y, Ryser S, Dembic Z, Borgulya P, Krimpenfort P, Berns A . In transgenic mice the introduced functional T cell receptor beta gene prevents expression of endogenous beta genes. Cell. 1988; 52(6):831-41. DOI: 10.1016/0092-8674(88)90425-4. View

5.
Wilson R, Lai E, Concannon P, Barth R, HOOD L . Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev. 1988; 101:149-72. DOI: 10.1111/j.1600-065x.1988.tb00736.x. View